Development of hairy cell leukemia in familial platelet disorder with predisposition to acute myeloid leukemia

被引:15
|
作者
Toya, Takashi [1 ]
Yoshimi, Akihide [1 ]
Morioka, Takehiko [2 ]
Arai, Shunya [1 ]
Lchikawa, Motoshi [1 ]
Usuki, Kensuke [2 ]
Kurokawa, Mineo [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo 1138655, Japan
[2] NTT Med Ctr Tokyo, Dept Hematol, Tokyo, Japan
关键词
BRAF; familial platelet disorder with predisposition to acute myeloid leukemia; hairy cell leukemia; RUNX1; MUTATIONS;
D O I
10.3109/09537104.2013.818636
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Familial platelet disorder with predisposition to acute myeloid leukemia (FPD/AML) is an autosomal dominant disorder characterized by mild to moderate thrombocytopenia with or without its impaired function, inherited RUNX1 mutation and high incidence of myeloid malignancy, such as myelodysplastic syndrome or acute myeloid leukemia. A 72-year-old male visited our institute because of gradually progressive pancytopenia and splenomegaly, and was diagnosed as having hairy cell leukemia. He was administered one course of intravenous cladribine (0.12 mg/kg, day 1-5) and achieved hematological complete response. Mutation analyses of RUNX1 gene were underwent because familial history of hematological malignancies evoked a possibility of FPD/AML. As a result, RUNX1 L445P mutation was identified in the peripheral blood and the mutation was considered as germ-line mutation because the same mutation was detected in the buccal mucosa. BRAF V600E mutation was also identified in the peripheral blood but not in the buccal mucosa. To our knowledge, this is the first report of B cell malignancy arising from FPD/AML.
引用
收藏
页码:300 / 302
页数:3
相关论文
共 50 条
  • [21] First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: correlation with the clinical phenotype
    Glembotsky, Ana C.
    Oyarzun, Cecilia P. Marin
    De Luca, Geraldine
    Marzac, Christophe
    Auger, Nathalie
    Goette, Nora P.
    Marta, Rosana F.
    Raslova, Hana
    Heller, Paula G.
    HAEMATOLOGICA, 2020, 105 (10) : E535 - E539
  • [22] Acute myeloid leukemia in a child with familial platelet disorder and a cryptic runx1 intragenic deletion
    Dodson, Lois M.
    Kurtz, Kristen J.
    Marcogliese, Andrea N.
    Friend, Brian D.
    Stevens, Alexandra M.
    Fisher, Kevin E.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2022, 39 (06) : 580 - 585
  • [23] Strategies for Analysis of Novel Molecular Variants in the RUNX1 Gene As a Cause of Familial Platelet Disorder with Predisposition to Acute Myeloid Leukemia (FPD/AML)
    Palma-Barqueros, Veronica
    Ruiz-Pividal, J. F.
    Maria Bastida, Jose
    Bohdan, Natalia
    Lopez-Andreu, M. J.
    Teruel-Montoya, Raul
    Isabel Anton, Ana
    Ferrer Marin, Francisca
    Padilla, Jose
    Cifuentes-Riquelme, Rosa
    Marin-Quilez, A.
    Martin Izquierdo, Marta
    Benito, Rocio
    Vicente, Vicente
    Maria Hernandez-Rivas, Jesus
    Ramon Gonzalez-Porras, Jose
    Rivera, Jose
    Luisa Lozano, Maria
    BLOOD, 2019, 134
  • [24] Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutations
    Toratani, Kazunori
    Watanabe, Mizuki
    Kanda, Junya
    Oka, Tomomi
    Hyuga, Mizuki
    Arai, Yasuyuki
    Iwasaki, Makoto
    Sakurada, Maki
    Nannya, Yasuhito
    Ogawa, Seishi
    Yamada, Takahiro
    Takaori-Kondo, Akifumi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (03) : 400 - 405
  • [25] Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutations
    Kazunori Toratani
    Mizuki Watanabe
    Junya Kanda
    Tomomi Oka
    Mizuki Hyuga
    Yasuyuki Arai
    Makoto Iwasaki
    Maki Sakurada
    Yasuhito Nannya
    Seishi Ogawa
    Takahiro Yamada
    Akifumi Takaori-Kondo
    International Journal of Hematology, 2023, 118 : 400 - 405
  • [26] HUMAN STEM CELL MODEL OF RUNX1 ALTERATIONS IN FAMILIAL PLATELET DISORDER WITH PREDISPOSITION TO ACUTE MYELOGENOUS LEUKEMIA (FPD/AML) DISEASE
    Manchev, V.
    Antony-Debre, I.
    Balayn, N.
    Bluteau, D.
    Legrand, C.
    Langlois, T.
    Tosca, L.
    Tachdjian, G.
    Mills, J. A.
    French, D. L.
    Weiss, M. J.
    Solary, E.
    Favier, R.
    Vainchenker, W.
    Raslova, H.
    HAEMATOLOGICA, 2014, 99 : 242 - 242
  • [27] Novel heritable mutation of the transcription factor RUNX1 as a cause of autosomal dominant familial platelet disorder with predisposition to acute myeloid leukemia (FPD/AML)
    Patton, William N.
    Suthers, Graeme
    Altree, Meryl
    Carnnichael, Catherine
    Wilkins, Ella
    Carroll, Jacqueline
    Rawlings, Lesley
    Scott, Hamish
    BLOOD, 2007, 110 (11) : 128B - 129B
  • [28] Genetic basis of myeloid transformation in familial platelet disorder/acute myeloid leukemia patients with haploinsufficient RUNX1 allele
    Sakurai, M.
    Kasahara, H.
    Yoshida, K.
    Yoshimi, A.
    Kunimoto, H.
    Watanabe, N.
    Shiraishi, Y.
    Chiba, K.
    Tanaka, H.
    Harada, Y.
    Harada, H.
    Kawakita, T.
    Kurokawa, M.
    Miyano, S.
    Takahashi, S.
    Ogawa, S.
    Okamoto, S.
    Nakajima, H.
    BLOOD CANCER JOURNAL, 2016, 6 : e392 - e392
  • [29] RUNX1-RELATED FAMILIAL PLATELET DISORDER WITH PREDISPOSITION TO ACUTE MYELOID LEUKEMIA (FPD/AML) PRESENTING WITH BLEEDING AND NORMAL PLATELET COUNT: THE IMPORTANCE OF RECOGNIZING THE PLATELET DYSFUNCTION AS PART OF THE PHENOTYPE
    Dugan, Stefanie N.
    Sullivan, Mia J.
    Springer, Mitchell G.
    Trapp-Stamborski, Valerie
    McCreery, Jamie
    Sharma, Ruchika
    Friedman, Kenneth D.
    Curtis, Brian R.
    Wang, Lijun
    Jobe, Shawn M.
    Botero, Juliana Perez
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E16 - E16
  • [30] Genetic basis of myeloid transformation in familial platelet disorder/acute myeloid leukemia patients with haploinsufficient RUNX1 allele
    M Sakurai
    H Kasahara
    K Yoshida
    A Yoshimi
    H Kunimoto
    N Watanabe
    Y Shiraishi
    K Chiba
    H Tanaka
    Y Harada
    H Harada
    T Kawakita
    M Kurokawa
    S Miyano
    S Takahashi
    S Ogawa
    S Okamoto
    H Nakajima
    Blood Cancer Journal, 2016, 6 : e392 - e392